Delivery Order V797D50492-15B50926F00000076
Award Date 4/1/26
Potential Completion Date 9/30/26
Potential Value $549K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Forest Hill, TX 76119, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Federal Correctional Institution Fort Worth awarded a $148,019.16 firm fixed-price delivery order to Takeda Pharmaceuticals America Inc. on October 1, 2025, with an ultimate completion date of January 30, 2026. This delivery order, issued under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB), represents a child contract to Takeda's broader single-award Blanket Purchase Agreement with the Department of Veterans Affairs National Acquisition Center valued at $131.0 million for the period...
- The Federal Correctional Institution Fort Worth issued a delivery order valued at $204,577.58 to Takeda Pharmaceuticals America Inc. for pharmacy services spanning January through September 2026. This firm fixed-price delivery order, awarded on February 28, 2026, operates under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB) as a child contract. The ordering activity represents the civilian healthcare operations of the Bureau of Prisons, which requires specialized pharmaceutical...
- The Department of Justice Bureau of Prisons Federal Correctional Institution Fort Worth awarded a firm fixed price delivery order to Takeda Pharmaceuticals America Inc., a subsidiary of the Japanese pharmaceutical company Takeda Pharmaceutical Company Limited. The $137,414.04 order is for the supply of various specialized pharmaceutical products, including treatments for hemophilia, immune deficiencies, hereditary angioedema, short bowel syndrome, and hypocalcemia, against Takeda's General...
- The Department of Justice's Bureau of Prisons Federal Correctional Institution in Fort Worth awarded a firm fixed-price delivery order to Takeda Pharmaceuticals America Inc., a subsidiary of the global biopharmaceutical company Takeda Pharmaceutical Company Limited, to provide various specialty pharmaceutical products. The award, valued at $44,602.86, was made against Takeda's existing General Services Administration (GSA) Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs...
- Takeda Pharmaceuticals America Inc. received a $319,551.93 firm fixed-price delivery order from the Federal Correctional Institution Fort Worth on October 1, 2025, with performance completion targeted for September 30, 2026. This delivery order, issued under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB), represents a child contract leveraging pre-negotiated terms and pricing established through Takeda's broader federal contracting vehicles. The award carries no set-aside designation,...
- Takeda Pharmaceuticals America Inc., a subsidiary of Japan-based Takeda Pharmaceutical Company Limited, was awarded a delivery order valued at $107,748.24 by the Federal Correctional Institution Fort Worth on August 1, 2025, with completion targeted for August 31, 2025. The award represents a firm fixed-price delivery order under the General Services Administration's Pharmaceuticals and Drugs Schedule (FSS-61-IB) and does not utilize a set-aside designation. The contract calls for delivery of...
- The Department of Justice Bureau of Prisons Federal Correctional Institution Fort Worth has awarded a firm fixed-price delivery order to Takeda Pharmaceuticals America Inc., a subsidiary of Takeda Pharmaceutical Company Limited, for medications valued at $98,465.40. The delivery order is placed against Takeda's Pharmaceuticals and Drugs General Services Administration (GSA) Federal Supply Schedule contract. Takeda specializes in providing specialty pharmaceutical products, including treatments...
- Takeda Pharmaceuticals America Inc. was awarded a $125,671.80 firm fixed price delivery order against its Pharmaceuticals and Drugs GSA Schedule contract by the Department of Justice Bureau of Prisons Federal Correctional Institution Fort Worth. The order is for FMC FORT WORTH TAKEDA MEDICATION for November 2023, with a completion date of February 27, 2024. No set-aside designation was applied. Takeda Pharmaceuticals America Inc. will leverage its parent company Takeda Pharmaceutical Company...
- This federal contract award is a delivery order valued at $113,436.24 issued by the Federal Correctional Institution (FCI) Fort Worth, a civilian agency, to Takeda Pharmaceuticals America Inc. under the General Services Administration (GSA) Pharmaceuticals and Drugs Schedule contract. The order is for a variety of Takeda's specialty pharmaceutical products, including treatments for hemophilia, immune deficiencies, hereditary angioedema, and cancer, to be delivered to the FCI Fort Worth...
- This is a $56,707.14 firm fixed-price delivery order awarded to Takeda Pharmaceuticals America Inc., a foreign-owned, for-profit pharmaceutical manufacturer, by the Federal Correctional Institution Fort Worth, a civilian agency. The order is part of the Takeda April FY25 contract, which has an ultimate completion date of April 30, 2025. The contract is not designated as a set-aside. Takeda Pharmaceuticals is a key supplier of specialized pharmaceutical products to federal agencies, including the...